Ann: Delivering Cancer Treatment Inside Cells - Nature Oncogene, page-38

Pure spec of course, but aligned with the company statements re mass screening, and potential deals re fpp with one of a number of Parties. Also if I think this then others may also, for example this got sold down to 2c when it was June July, and it is much closer to sept and we have 3 bid. Even 3.1 and recently 3.5. It seems to be playing out that progress is possible this quarter and sp will react accordingly. I am quietly confident, esp since the recent shuffle of major holders.... and our new ceo to sell this.